Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • PDGFR
    (2)
  • VEGFR
    (2)
  • c-Kit
    (2)
  • Tyrosinase
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Cancer
    (2)
Filter
Search Result
Results for "

ha29

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    4
    TargetMol | All_Pathways
  • HA-29
    T70694142733-19-5
    HA-29 is an inhibitor of thromboxane A2 and prostaglandin endoperoxide receptors.
    • $2,120
    8-10 weeks
    Size
    QTY
  • ID110460003
    T719461428367-46-7
    ID110460003 is a novel μ,δ-Opioid Receptor Dual-Biased Agonist, Overcoming the Limitation of Prior Biased Agonist.
    • $1,520
    6-8 weeks
    Size
    QTY
  • Toceranib Phosphate
    SU11654 phosphate, PHA 291639 phosphate
    T7394874819-74-6
    Toceranib Phosphate (SU11654 phosphate), is a selective inhibitor of the tyrosine kinase activity of several members of the split kinase RTK family, including Flk-1/KDR, PDGFR
    • $41
    In Stock
    Size
    QTY
  • Toceranib
    SU11654, PHA 291639E
    T13178356068-94-5
    Toceranib (PHA 291639E) phosphate is an orally active inhibitor of tyrosine kinase (RTK) receptor, and it potently inhibits PDGFR, VEGFR, and Kit(with Kis of 5 and 6 nM for PDGFRβ and Flk-1/KDR, respectively), has antitumor and antiangiogenic activity.
    • $39
    In Stock
    Size
    QTY